Literature DB >> 7915791

Thrombogenic potential of factor XI concentrate.

P H Bolton-Maggs, B T Colvin, B T Satchi, C A Lee, G S Lucas.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7915791     DOI： 10.1016/s0140-6736(94)92237-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  4 Plasma for Therapeutic Use.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  A proposal for managing bleeding in patients on therapeutic factor XI(a) inhibitors.

Authors:  Ophira Salomon; David Gailani
Journal:  J Thromb Haemost       Date:  2021-11-21       Impact factor: 16.036

3.  Uneventful cesarean delivery with administration of factor XI concentrate in a patient with severe factor XI deficiency.

Authors:  Georgios Mavromatidis; Konstantinos Dinas; Dimitrios Delkos; Fotios Goutzioulis; Christos Vosnakis; Emmanouel Hatzipantelis; Vassilia Garipidou; David Rousso
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

Review 4.  Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

5.  Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.

Authors:  F Bauduer; E de Raucourt; C Boyer-Neumann; M Trossaert; P Beurrier; A Faradji; J Peynet; J-Y Borg; P Chamouni; C Chatelanaz; C Henriet; F Bridey; J Goudemand
Journal:  Haemophilia       Date:  2015-03-26       Impact factor: 4.287
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.